Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes
Authors
- Niels Jongs (ORCID: https://orcid.org/0000-0002-0882-3656)
- Hiddo J.L. Heerspink (ORCID: https://orcid.org/0000-0002-3126-3730)
- Jelle M. Beernink (ORCID: https://orcid.org/0000-0002-4615-9012)
- C. J. A. Doelman
- Gozewijn D. Laverman (ORCID: https://orcid.org/0000-0002-8716-7115)
Institutions
- University Medical Center Groningen (NL)
- Ziekenhuis Groep Twente (NL)
- University of Twente (NL)
Funders
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- CSL Behring
- Novo Nordisk
- Universitair Medisch Centrum Groningen
- Idorsia Pharmaceuticals